Insight Genetics Snags $1.5M NCI Award for NSCLC Assay | GenomeWeb

NEW YORK (GenomeWeb News) — Insight Genetics said yesterday that it has received a new $1.5 million grant from the National Cancer Institute.

The Phase II Small Business Innovation Research grant from the National Cancer Institute will enable Nashville, Tenn.-based Insight to continue developing Insight ALK Resistance, a molecular diagnostic test to help clinicians monitor therapeutic resistance in non-small cell lung cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.